Coronavirus: Recommendations for Patient Families

As students return to the classroom this fall, the UMDF’s Scientific and Medical Advisory Board has issued the following recommendations for mitochondrial disease patient families.

On Saturday, February 20, 2021, at Noon Eastern Time, Francis Collins, MD, PhD, Director of the National Institutes of Health, will share with us why it is critical that individuals living with chronic diseases and conditions receive the coronavirus vaccine.

There have been questions posed to UMDF regarding recommendations about people with
mitochondrial disease receiving one of the COVID-19 vaccines in development. As of this date,

As the leading advocacy group representing patients with mitochondrial disease or metabolic disorders, we thank your state health department for its ongoing efforts to distribute COVID-19 vaccinations equitably and effectively. We respectfully write to encourage you to include individuals living with mitochondrial disease or other metabolic disorders as a priority in the administration of any FDA-approved or authorized COVID-19 vaccine.

As a service to our community, the UMDF Scientific and Medical Advisory Board continues to monitor credible reports about COVID-19 illness and provide periodic updates.